NO963462L - Paramunitetinducer basert på kombinasjoner av poxvirus komponenter, fremgangsmåte for fremstilling derav og anvendelse som medikament - Google Patents

Paramunitetinducer basert på kombinasjoner av poxvirus komponenter, fremgangsmåte for fremstilling derav og anvendelse som medikament

Info

Publication number
NO963462L
NO963462L NO963462A NO963462A NO963462L NO 963462 L NO963462 L NO 963462L NO 963462 A NO963462 A NO 963462A NO 963462 A NO963462 A NO 963462A NO 963462 L NO963462 L NO 963462L
Authority
NO
Norway
Prior art keywords
combinations
paramunity inducers
drug
preparation
poxvirus components
Prior art date
Application number
NO963462A
Other languages
English (en)
Other versions
NO319250B1 (no
Inventor
Anton Mayr
Original Assignee
Anton Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anton Mayr filed Critical Anton Mayr
Publication of NO963462L publication Critical patent/NO963462L/no
Publication of NO319250B1 publication Critical patent/NO319250B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19963462A 1994-02-23 1996-08-20 Paramunitetinducer basert pa poxviruskomponenter, fremgangsmate for fremstilling derav og anvendelse som farmasoytiske sammensetninger. NO319250B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4405841A DE4405841C1 (de) 1994-02-23 1994-02-23 Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
PCT/EP1995/000160 WO1995022978A1 (en) 1994-02-23 1995-01-17 Paramunity inducer based on combinations of poxvirus components, process to prepare it and its use as medicament

Publications (2)

Publication Number Publication Date
NO963462L true NO963462L (no) 1996-08-20
NO319250B1 NO319250B1 (no) 2005-07-04

Family

ID=6511005

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19963462A NO319250B1 (no) 1994-02-23 1996-08-20 Paramunitetinducer basert pa poxviruskomponenter, fremgangsmate for fremstilling derav og anvendelse som farmasoytiske sammensetninger.

Country Status (20)

Country Link
US (1) US6805870B1 (no)
EP (1) EP0669133B1 (no)
JP (1) JP2873880B2 (no)
KR (1) KR100196204B1 (no)
CN (1) CN1142187A (no)
AT (1) ATE153242T1 (no)
AU (1) AU690625B2 (no)
BR (1) BR9506882A (no)
CA (1) CA2182207C (no)
DE (2) DE4405841C1 (no)
DK (1) DK0669133T3 (no)
ES (1) ES2102081T3 (no)
FI (1) FI116557B (no)
GR (1) GR3023508T3 (no)
HU (1) HU220972B1 (no)
NO (1) NO319250B1 (no)
NZ (1) NZ278079A (no)
PL (1) PL182132B1 (no)
SI (1) SI0669133T1 (no)
WO (1) WO1995022978A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2247336C (en) * 1996-02-28 2008-06-17 Bayer Aktiengesellschaft Parapoxviruses containing foreign dna, their production and their use in vaccines
ES2125846T3 (es) * 1996-04-15 2001-12-16 Anton Prof Dr Med Vet Dr Mayr Nuevas indicaciones para el empleo de inductores de parainmunidad multipotentes a partir de virus de viruela o virus de paraviruela atenuados, no inmunogenos, como medicamento.
JPH1192390A (ja) * 1997-09-17 1999-04-06 Natl Fedelation Of Agricult Coop Assoc ストレス状態改善剤
WO2000000216A2 (en) * 1998-06-26 2000-01-06 Aventis Pasteur Use of poxviruses as enhancer of specific immunity
DE19922407A1 (de) * 1999-05-14 2000-11-16 Bayer Ag Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus
US6682742B1 (en) * 1999-05-28 2004-01-27 Gsf Forschungszentrum Fur Unwelt Und Gesundheit Gmbh Vector for integration of heterologous sequences into poxviral genomes
SI1263936T1 (sl) * 2000-03-14 2006-06-30 Bavarian Nordic As Spremenjen sev modificiranega virusa vakcinacije Ankara (MVA)
PL360839A1 (en) * 2000-07-11 2004-09-20 Bayer Aktiengesellschaft Use of strains of the parapox ovis virus against organ fibrosis
DE10122233A1 (de) * 2000-07-11 2002-01-24 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen
DE50109630D1 (de) 2000-07-11 2006-06-01 Bayer Healthcare Ag Verwendung von stämmen des parapoxvirus ovis zur herstellung von antiviralen arzneimitteln und arzneimitteln gegen krebs
DE10122451A1 (de) * 2000-07-11 2002-04-04 Bayer Ag Verwendung von Stämmen des Parapoxvirus ovis zur Herstellung von antiviralen Arzneimitteln und Arzneimitteln gegen Krebs
US7628980B2 (en) * 2000-11-23 2009-12-08 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
CN101676389A (zh) 2000-11-23 2010-03-24 巴法里安诺迪克有限公司 改良安卡拉痘苗病毒变体
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
US7097842B2 (en) * 2000-11-23 2006-08-29 Bavarian Nordic A/S Modified vaccinia virus ankara for the vaccination of neonates
UA82466C2 (uk) * 2001-07-18 2008-04-25 Бавариан Нордика А/С Спосіб посилення ампліфікації хордопоксвірусу
EP2345665A3 (en) 2001-12-04 2012-02-15 Bavarian Nordic A/S Flavivirus NS1 subunit vaccine
EP1499355A4 (en) * 2001-12-07 2005-10-05 Bayer Pharmaceuticals Corp USE OF PARAPOX B2L PROTEIN FOR THE TREATMENT OF CANCER AND THE MODIFICATION OF IMMUNE RESPONSES
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
US6723329B2 (en) * 2001-12-07 2004-04-20 Board Of Regents, The University Of Texas System Use of parapox B2L protein to modify immune responses to administered antigens
DE60314823T3 (de) * 2002-04-19 2017-11-16 Bavarian Nordic A/S Modifizierte variante des vaccinia ankara virus als impfstoff für neugeborene
DK1434858T4 (en) 2002-09-05 2019-04-01 Bavarian Nordic As PROCEDURE FOR AMPLIFICATION OF A POXVIRUS UNDER SERUM-FREE CONDITIONS
DE102004003572A1 (de) 2004-01-23 2005-08-18 Bavarian Nordic A/S Monoparamunitätsinducer basierend auf attenuierten Myxomaviren des Kaninchens
EP1765370B1 (en) * 2004-07-13 2009-09-09 AiCuris GmbH & Co. KG Parapoxviruses in combination with other antiviral agents for the treatment of hiv/aids
DE102004046391A1 (de) * 2004-09-24 2006-04-06 Bioveta Ag Neuer Impfstoff für veterinäre und humanmedizinische Prophylaxe und Therapie
DE102005027956B4 (de) * 2005-06-16 2009-10-22 Mayr, Anton, Prof. Dr. Dr. h.c. mult. Hochattenuierte Poxvirusstämme, Verfahren zu ihrer Herstellung und deren Verwendung als Paramunitätsinducer oder zur Herstellung von Vektor-Vakzinen
US20140255447A1 (en) * 2013-03-05 2014-09-11 Biomune Company Production of avian embryo cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern

Also Published As

Publication number Publication date
ES2102081T3 (es) 1997-07-16
AU1416795A (en) 1995-09-11
HU220972B1 (hu) 2002-07-29
JP2873880B2 (ja) 1999-03-24
PL316024A1 (en) 1996-12-23
FI963277A0 (fi) 1996-08-22
EP0669133B1 (de) 1997-05-21
CA2182207A1 (en) 1995-08-31
CA2182207C (en) 2000-02-29
JPH09504803A (ja) 1997-05-13
NO319250B1 (no) 2005-07-04
CN1142187A (zh) 1997-02-05
PL182132B1 (pl) 2001-11-30
FI116557B (fi) 2005-12-30
KR970701062A (ko) 1997-03-17
AU690625B2 (en) 1998-04-30
NZ278079A (en) 1998-01-26
DE4405841C1 (de) 1995-01-05
EP0669133A1 (de) 1995-08-30
FI963277A (fi) 1996-08-22
HUT75545A (en) 1997-05-28
GR3023508T3 (en) 1997-08-29
KR100196204B1 (ko) 1999-06-15
US6805870B1 (en) 2004-10-19
SI0669133T1 (en) 1997-10-31
ATE153242T1 (de) 1997-06-15
DE59402826D1 (de) 1997-06-26
WO1995022978A1 (en) 1995-08-31
BR9506882A (pt) 1997-08-19
DK0669133T3 (da) 1997-07-14
HU9601947D0 (en) 1996-09-30

Similar Documents

Publication Publication Date Title
NO963462L (no) Paramunitetinducer basert på kombinasjoner av poxvirus komponenter, fremgangsmåte for fremstilling derav og anvendelse som medikament
TR199901174T2 (xx) Yeni heterosiklilmetil-ikameli pirazol t�revleri.
DK1036058T3 (da) Adamantanderivater
DK1036059T3 (da) Adamantanderivater
SE9704546D0 (sv) Novel compounds
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
DE69324601D1 (de) Multifunktionelle neurotrophe faktoren
NO871599D0 (no) Sammensetning for stimulering av kondrocytter og osteoblaster (osseinhydroksyapatittforbindelse), fremgangsmaate for fremstilling derav og farmasoeytiske preparater inneholdende sammensetningen.
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
NO883047D0 (no) Substituerte benzimidazoler, fremgangsmaate til deres fremstilling, farmasoeytise tilberedninger inneholdende dem og deres anvendelse.
GT199900062A (es) Preparados efervescentes.
NO863460D0 (no) Fremgangsmaate til fremstilling av 6-fenoksymetyl-4-hydroksy-tetrahydropyran-2-on, fremgangsmaate til deres fremstilling, og deres anvendelse som legemiddel, farmasoeytiske preparater og mellomprodukter.
HUT41002A (en) Process for preparing anticonvulsives
ZA843489B (en) 4-oxothiazolidin-2-ylidene-acetamide derivatives,processes for their preparation and their use in the combating of diseases of the central nervous system
IT8719700A0 (it) 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono.
PT83253A (en) Process for preparing p-acylaminobenzamides
AU3406089A (en) Novel strobilurine derivatives, their preparation and their use
HK1036070A1 (en) 5-imino-13-deoxy anthracycline derivatives, their uses and processes for preparing them.
IT8621836A0 (it) Nuovi derivati del catecolo, procedimento per la loro preparazione e composizione terapeutiche che li contengono.
AU2001274138A1 (en) Propanolaminotetralines, preparation thereof and compositions containing same
WO2001048205A3 (en) Murine neu sequences and methods of use therefor
IT8821137A0 (it) Fosfatidilcoline idrosolubili, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.
UA23872A (uk) Лікувальний препарат (його варіанти)
GB9314133D0 (en) New process

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ZACCO NORWAY AS POSTBOKS 2003 VIKA OSLO, 0125 NO